Skip to content
Use caution Drug recall · FDA · Published June 4, 2015

Fresenius Kabi Recalls Rifampin for Injection Due to Impurities

Fresenius Kabi USA recalls specific lots of Rifampin for Injection due to failed impurity and degradation specifications. Check your vial details.

🇺🇸 FDA recall #D-1234-2015DrugFresenius Kabi ›
Take action

Contact the company

Recalling firmFresenius Kabi USA, LLC3 Corporate Dr · Lake Zurich, IL 60047-8930
✎ GovInfoNow plain-language explainer

Fresenius Kabi USA, LLC is recalling a specific quantity of Rifampin for Injection, USP 600mg/vial because the product failed impurity and degradation specifications. The affected vials may have out-of-specification color or impurity levels. This recall affects 7,593 vials distributed nationwide, including Hawaii and Puerto Rico. Read more at govinfonow.com/recall/44206-fresenius-kabi-usa-llc-recalls-rifampin-for-injection-usp-600mg.

Source Summary by GovInfoNow · govinfonow.com/recall/44206-fresenius-kabi-usa-llc-recalls-rifampin-for-injection-usp-600mg · Updated October 12, 2026 · FDA enforcement record: FDA #D-1234-2015

Cite this page

“Fresenius Kabi Recalls Rifampin for Injection Due to Impurities.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44206-fresenius-kabi-usa-llc-recalls-rifampin-for-injection-usp-600mg. Based on FDA recall #D-1234-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1234-2015%22&limit=1).

The FDA announced on June 4, 2015, that Fresenius Kabi USA, LLC voluntarily recalled Rifampin for Injection due to failed impurity and degradation specifications. The recall affects 7,593 vials distributed nationwide, in Hawaii, and Puerto Rico.

How to tell if you have it

  • Brand: Fresenius Kabi
  • Product: Rifampin for Injection, USP 600mg/vial in a 20mL vial
  • NDC: 63323-351-20
  • Lot codes: 6109469, 6109470
  • Expiration date: 10/2016

The hazard

The product is out-of-specification for color, impurity, and degradation. The recall was classified as a Class II recall.

Context

GovInfoNow's records show Fresenius Kabi USA, LLC has had 65 other recalls on record since September 27, 2012. Recent recalls include the August 10, 2026 Tyenne Injection recall for glass particles and the August 4, 2026 Morphine Syringes recall for wrong labeling. Other recent recalls of similar products include the March 3, 2026 Temozolomide capsules recall due to impurity issues and the September 18, 2026 Fosfomycin Tromethamine Granules recall due to impurities.

How to tell if you have this one

Look for Rifampin for Injection, USP 600mg/vial in a 20mL vial. Check for NDC 63323-351-20 and Lot numbers 6109469 or 6109470 with an expiration date of 10/2016.

  • Brand
    Fresenius Kabi
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check lot numbers

    Verify if your vials match Lot numbers 6109469 or 6109470 with an expiration date of 10/2016.

  2. Contact provider

    If you have the recalled lots, contact your healthcare provider or pharmacist for instructions on what to do next.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide,Hawaii, and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 11 months after the firm started it.

1. Firm started the recall: Jun 4, 201512. FDA classified it Class II: Jul 14, 201523. Published in FDA’s Enforcement Report: Jul 22, 201534. FDA terminated the recall: May 19, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the NDC number for the recalled item?

The National Drug Code (NDC) is 63323-351-20.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1234-2015 (June 4, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1234-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA